Office of The Director, National Institutes of Health; Notice of Meeting, 61921-61922 [2019-24673]
Download as PDF
<![CDATA[
Federal Register / Vol. 84, No. 220 / Thursday, November 14, 2019 / Notices
khammond on DSKJM1Z7X2PROD with NOTICES
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Myalgic
Encephalomyelitis/Chronic Fatigue
Syndrome.
Date: December 4, 2019.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Telephone Conference
Call).
Contact Person: M Catherine Bennett,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5182,
MSC 7846, Bethesda, MD 20892, 301–435–
1766, bennettc3@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel PAR Panel;
Cancer Health Disparities.
Date: December 5, 2019.
Time: 8:00 a.m. to 10:00 a.m.
Agenda: To review and evaluate grant
applications.
Place: Embassy Suites at the Chevy Chase
Pavilion, 4300 Military Road NW,
Washington, DC 20015.
Contact Person: Rolf Jakobi, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6187,
MSC 7806, Bethesda, MD 20892, 301–495–
1718, jakobir@mail.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: AIDS and Related Research.
Date: December 6, 2019.
Time: 9:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Barna Dey, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3184,
Bethesda, MD 20892, 301–451–2796, bdey@
mail.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Program
Projects: Combination Therapy for HIV
Eradication.
Date: December 6, 2019.
Time: 10:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Shiv A Prasad, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5220,
MSC 7852, Bethesda, MD 20892, 301–443–
5779, prasads@csr.nih.gov.
VerDate Sep<11>2014
17:47 Nov 13, 2019
Jkt 250001
Name of Committee: Center for Scientific
Review Special Emphasis Panel PAR Panel;
Adverse Drug Reaction.
Date: December 6, 2019.
Time: 10:00 a.m. to 2:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Alexander D Politis, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3210,
MSC 7808, Bethesda, MD 20892, (301) 435–
1150, politisa@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Cancer therapeutics and biomarkers.
Date: December 6, 2019.
Time: 11:00 a.m. to 2:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Telephone Conference
Call).
Contact Person: Mehrdad Mohseni, MD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5211,
MSC 7854, Bethesda, MD 20892, 301–435–
0484, mohsenim@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Language, Communication,
Cognition and Perception.
Date: December 6, 2019.
Time: 11:30 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Katherine Colona Morasch,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3170,
Bethesda, MD 20892, moraschkc@
csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: November 7, 2019.
Ronald J. Livingston, Jr.,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2019–24674 Filed 11–13–19; 8:45 am]
BILLING CODE 4140–01–P
PO 00000
Frm 00054
Fmt 4703
Sfmt 4703
61921
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Eunice Kennedy Shriver National
Institute of Child Health & Human
Development; Amended Notice of
Meeting
Notice is hereby given of a change in
the meeting of the Population Sciences
Subcommittee, which was published in
the Federal Register on February 28,
2019, 84 FR 6808.
The meeting date has changed from a
two-day meeting on November 14th and
November 15th, 2019 to a one-day
meeting on November 14th, 2019. The
meeting is closed to the public.
Dated: November 7, 2019.
Ronald J. Livingston, Jr.,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2019–24675 Filed 11–13–19; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Office of The Director, National
Institutes of Health; Notice of Meeting
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the Novel and Exceptional
Technology and Research Advisory
Committee.
The meeting will be open to the
public, with attendance limited to space
available. Individuals who plan to
attend and need special assistance, such
as sign language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting. The meetings
will also be videocast and can be
accessed from the NIH Videocasting and
Podcasting website (https://
videocast.nih.gov/).
Name of Committee: Novel and
Exceptional Technology and Research
Advisory Committee.
Date: December 5, 2019.
Time: 11:00 a.m. to 5:15 p.m.
Agenda: The Novel and Exceptional
Technology and Research Advisory
Committee (NExTRAC) will discuss (1)
pathways for responsible innovation in
emerging biotechnologies; (2) characteristics
of emerging biotechnologies, including
presentations on horizon scanning, gene
editing in the clinic, gene drives,
neurotechnology, artificial intelligence, and
synthetic biology; and (3) proactively
addressing scientific and societal
implications of emerging biotechnologies. In
E:\FR\FM\14NON1.SGM
14NON1
khammond on DSKJM1Z7X2PROD with NOTICES
61922
Federal Register / Vol. 84, No. 220 / Thursday, November 14, 2019 / Notices
addition, charge(s) to the committee will be
presented.
Place: National Institutes of Health,
Building 35A, Room 620/630, 9000 Rockville
Pike, Bethesda, MD 20892.
Name of Committee: Novel and
Exceptional Technology and Research
Advisory Committee.
Date: December 6, 2019.
Time: 9:00 a.m. to 2:45 p.m.
Agenda: The Novel and Exceptional
Technology and Research Advisory
Committee (NExTRAC) will discuss (1)
pathways for responsible innovation in
emerging biotechnologies; (2) characteristics
of emerging biotechnologies, including
presentations on horizon scanning, gene
editing in the clinic, gene drives,
neurotechnology, artificial intelligence, and
synthetic biology; and (3) proactively
addressing scientific and societal
implications of emerging biotechnologies. In
addition, charge(s) to the committee will be
presented.
Place: National Institutes of Health,
Building 35A, Room 620/630, 9000 Rockville
Pike, Bethesda, MD 20892.
Contact Person: Shayla Beckham,
Management Program Analyst, Office of
Science Policy, National Institutes of Health,
6705 Rockledge Drive, Room 750, Bethesda,
MD 20892–9606, 301–496–9838,
shayla.beckham@nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has
instituted stringent procedures for entrance
onto the NIH campus. All visitor vehicles,
including taxicabs, hotel and airport shuttles
will be inspected before being allowed on
campus. Visitors will be asked to show one
form of identification (for example, a
government-issued photo ID, driver’s license,
or passport) and to state the purpose of their
visit.
Information is also available on the
NExTRAC web page: https://osp.od.nih.gov/
biotechnology/novel-exceptional-technologyresearch-advisory-committee/, where an
agenda and any additional information for
the meeting will be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.14, Intramural Research
Training Award; 93.22, Clinical Research
Loan Repayment Program for Individuals
from Disadvantaged Backgrounds; 93.232,
Loan Repayment Program for Research
Generally; 93.39, Academic Research
Enhancement Award; 93.936, NIH Acquired
Immunodeficiency Syndrome Research Loan
Repayment Program; 93.187, Undergraduate
Scholarship Program for Individuals from
Disadvantaged Backgrounds, National
Institutes of Health, HHS)
Dated: November 7, 2019.
Ronald J. Livingston, Jr.,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2019–24673 Filed 11–13–19; 8:45 am]
BILLING CODE 4140–01–P
VerDate Sep<11>2014
17:47 Nov 13, 2019
Jkt 250001
DEPARTMENT OF HOMELAND
SECURITY
Federal Emergency Management
Agency
[Docket ID FEMA–2019–0025; OMB No.
1660–0017]
Agency Information Collection
Activities: Proposed Collection;
Comment Request; Public Assistance
Program
Federal Emergency
Management Agency, DHS.
ACTION: Notice and request for
comments.
AGENCY:
The Federal Emergency
Management Agency, as part of its
continuing effort to reduce paperwork
and respondent burden, invites the
general public to take this opportunity
to comment on a revision of a currently
approved information collection. In
accordance with the Paperwork
Reduction Act of 1995, this notice seeks
comments concerning information
collected for the Public Assistance (PA)
program eligibility determinations,
grants management, and compliance
with Federal laws and regulations.
DATES: Comments must be submitted on
or before January 13, 2020.
ADDRESSES: To avoid duplicate
submissions to the docket, please use
only one of the following means to
submit comments:
(1) Online. Submit comments at
www.regulations.gov under Docket ID
FEMA–2019–0025. Follow the
instructions for submitting comments.
(2) Mail. Submit written comments to
Docket Manager, Office of Chief
Counsel, DHS/FEMA, 500 C Street SW,
8NE, Washington, DC 20472–3100.
All submissions received must
include the agency name and Docket ID.
Regardless of the method used for
submitting comments or material, all
submissions will be posted, without
change, to the Federal eRulemaking
Portal at https://www.regulations.gov,
and will include any personal
information you provide. Therefore,
submitting this information makes it
public. You may wish to read the
Privacy Act notice that is available via
the link in the footer of
www.regulations.gov.
SUMMARY:
FOR FURTHER INFORMATION CONTACT:
Rachel Hildebrand, Process
Improvement Section Chief, Public
Assistance Program Delivery Branch,
202–646–3484. You may contact the
Information Management Division for
copies of the proposed collection of
information at email address: FEMA-
PO 00000
Frm 00055
Fmt 4703
Sfmt 4703
Information-Collections-Management@
fema.dhs.gov.
The
Robert T. Stafford Disaster Relief and
Emergency Assistance Act, 42 U.S.C.
5121–5207 (the Stafford Act), authorizes
grants to assist State, Tribal, and local
governments and certain Private NonProfit entities with the response to and
recovery from disasters following
Presidentially declared major disasters
and emergencies. 44 CFR part 206
specifies the information collections
necessary to facilitate the provision of
assistance under the Public Assistance
(PA) Program. 44 CFR 206.202 describes
the general application procedures for
the PA Program.
FEMA is seeking a revision to the
already existing collection of
information, OMB Control Number
1660–0017, because FEMA proposes
changing the title from ‘‘Request for
Appeals and Recommendation/No
Forms’’ to ‘‘Request for Appeals or
Arbitrations and Recommendations/No
Forms.’’ Section 1219 of the Disaster
Recovery Reform Act of 2018, which
amended Section 423(d) of the Stafford
Act (42 U.S.C. 5189a), provides a right
of arbitration to certain applicants of the
PA Program that have a dispute
concerning the eligibility for assistance
or repayment of assistance. Plus, the
annual cost to the Federal Government
is increasing from $805,311.96 to
$1,891,473. Finally, there has been a
change in the annual burden hours due
to a correction of errors in burden
estimates. For example, in the past,
FEMA incorrectly used 1.3 hours to
represent 1.5 hours for FEMA Form
009–0–91.
SUPPLEMENTARY INFORMATION:
Collection of Information
Title: Public Assistance Program.
Type of Information Collection:
Revision of a currently approved
collection.
OMB Number: 1660–0017.
FEMA Forms: FEMA Form–009–0–49
Request for Public Assistance; FEMA
Form 009–0–91 Project Worksheet (PW);
FEMA Form 009–0–91A Project
Worksheet (PW)—Damage Description
and Scope of Work Continuation Sheet;
FEMA Form 009–0–91B Project
Worksheet (PW)—Cost Estimate
Continuation Sheet; FEMA Form 009–
0–91C Project Worksheet (PW)—Maps
and Sketches Sheet; FEMA Form 009–
0–91D Project Worksheet (PW)—Photo
Sheet; FEMA Form 009–0–120 Special
Considerations Questions; FEMA Form
009–0–121 PNP Facility Questionnaire;
FEMA Form 009–0–123 Force Account
Labor Summary Record; FEMA Form
009–0–124 Materials Summary Record;
E:\FR\FM\14NON1.SGM
14NON1
]]>Agencies
[Federal Register Volume 84, Number 220 (Thursday, November 14, 2019)]
[Notices]
[Pages 61921-61922]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-24673]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Office of The Director, National Institutes of Health; Notice of
Meeting
Pursuant to section 10(a) of the Federal Advisory Committee Act, as
amended, notice is hereby given of a meeting of the Novel and
Exceptional Technology and Research Advisory Committee.
The meeting will be open to the public, with attendance limited to
space available. Individuals who plan to attend and need special
assistance, such as sign language interpretation or other reasonable
accommodations, should notify the Contact Person listed below in
advance of the meeting. The meetings will also be videocast and can be
accessed from the NIH Videocasting and Podcasting website (https://videocast.nih.gov/).
Name of Committee: Novel and Exceptional Technology and Research
Advisory Committee.
Date: December 5, 2019.
Time: 11:00 a.m. to 5:15 p.m.
Agenda: The Novel and Exceptional Technology and Research
Advisory Committee (NExTRAC) will discuss (1) pathways for
responsible innovation in emerging biotechnologies; (2)
characteristics of emerging biotechnologies, including presentations
on horizon scanning, gene editing in the clinic, gene drives,
neurotechnology, artificial intelligence, and synthetic biology; and
(3) proactively addressing scientific and societal implications of
emerging biotechnologies. In
[[Page 61922]]
addition, charge(s) to the committee will be presented.
Place: National Institutes of Health, Building 35A, Room 620/
630, 9000 Rockville Pike, Bethesda, MD 20892.
Name of Committee: Novel and Exceptional Technology and Research
Advisory Committee.
Date: December 6, 2019.
Time: 9:00 a.m. to 2:45 p.m.
Agenda: The Novel and Exceptional Technology and Research
Advisory Committee (NExTRAC) will discuss (1) pathways for
responsible innovation in emerging biotechnologies; (2)
characteristics of emerging biotechnologies, including presentations
on horizon scanning, gene editing in the clinic, gene drives,
neurotechnology, artificial intelligence, and synthetic biology; and
(3) proactively addressing scientific and societal implications of
emerging biotechnologies. In addition, charge(s) to the committee
will be presented.
Place: National Institutes of Health, Building 35A, Room 620/
630, 9000 Rockville Pike, Bethesda, MD 20892.
Contact Person: Shayla Beckham, Management Program Analyst,
Office of Science Policy, National Institutes of Health, 6705
Rockledge Drive, Room 750, Bethesda, MD 20892-9606, 301-496-9838,
[email protected].
Any interested person may file written comments with the
committee by forwarding the statement to the Contact Person listed
on this notice. The statement should include the name, address,
telephone number and when applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has instituted stringent
procedures for entrance onto the NIH campus. All visitor vehicles,
including taxicabs, hotel and airport shuttles will be inspected
before being allowed on campus. Visitors will be asked to show one
form of identification (for example, a government-issued photo ID,
driver's license, or passport) and to state the purpose of their
visit.
Information is also available on the NExTRAC web page: https://osp.od.nih.gov/biotechnology/novel-exceptional-technology-research-advisory-committee/, where an agenda and any additional information
for the meeting will be posted when available.
(Catalogue of Federal Domestic Assistance Program Nos. 93.14,
Intramural Research Training Award; 93.22, Clinical Research Loan
Repayment Program for Individuals from Disadvantaged Backgrounds;
93.232, Loan Repayment Program for Research Generally; 93.39,
Academic Research Enhancement Award; 93.936, NIH Acquired
Immunodeficiency Syndrome Research Loan Repayment Program; 93.187,
Undergraduate Scholarship Program for Individuals from Disadvantaged
Backgrounds, National Institutes of Health, HHS)
Dated: November 7, 2019.
Ronald J. Livingston, Jr.,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2019-24673 Filed 11-13-19; 8:45 am]
BILLING CODE 4140-01-P
